Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies

Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies

Item
http://www.wikidata.org/entity/Q28741027
Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175Biochemical analysis of the Plasmodium falciparum erythrocyte-binding antigen-175 (EBA175)-glycophorin-A interaction: implications for vaccine designPlasmodium falciparum ligand binding to erythrocytes induce alterations in deformability essential for invasionRH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum.Different Regions of Plasmodium falciparum Erythrocyte-Binding Antigen 175 Induce Antibody Responses to Infection of Varied Efficacy.Triggers of key calcium signals during erythrocyte invasion by Plasmodium falciparumCritical glycosylated residues in exon three of erythrocyte glycophorin A engage Plasmodium falciparum EBA-175 and define receptor specificity.The epitope of monoclonal antibodies blocking erythrocyte invasion by Plasmodium falciparum map to the dimerization and receptor glycan binding sites of EBA-175.Multimeric assembly of host-pathogen adhesion complexes involved in apicomplexan invasion.Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.A quantitative assay for binding and inhibition of Plasmodium falciparum Erythrocyte Binding Antigen 175 reveals high affinity binding depends on both DBL domains.Implications from predicted B-cell and T-cell epitopes of Plasmodium falciparum merozoite proteins EBA175-RII and Rh5.P. falciparum RH5-Basigin interaction induces changes in the cytoskeleton of the host RBC.
P2860

Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies

Item
http://www.wikidata.org/entity/Q28741027
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Delineation of stage specific ...... egion II monoclonal antibodies
@ast
Delineation of stage specific ...... egion II monoclonal antibodies
@en
Delineation of stage specific ...... egion II monoclonal antibodies
@nl
type
label
Delineation of stage specific ...... egion II monoclonal antibodies
@ast
Delineation of stage specific ...... egion II monoclonal antibodies
@en
Delineation of stage specific ...... egion II monoclonal antibodies
@nl
prefLabel
Delineation of stage specific ...... egion II monoclonal antibodies
@ast
Delineation of stage specific ...... egion II monoclonal antibodies
@en
Delineation of stage specific ...... egion II monoclonal antibodies
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
Delineation of stage specific ...... egion II monoclonal antibodies
@en
P2093
P2860
P304
P31
P3181
P356
10.1371/JOURNAL.PONE.0018393
P407
P433
P478
P50
P577
P5875
P698
P921
P932